Stocks · News reference

8-K filing — Niki BioSolutions, Inc. (NIKI)

Sep 14, 2026, 8:00 PMSEC EDGAR

Filed: 2026-09-14 AccNo: 0001213900-26-099695 Size: 9 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: edgar
Observed: Sep 14, 2026, 8:00 PM
Checked: Sep 14, 2026, 8:00 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaSep 14, 2026, 12:31 PMBenzinga Newsdesk
Niki BioSolutions' DiamiR Announces Engagement Of Fios Genomics For Bioinformatics And Biostatistics Analysis Supporting Alzheimer's Disease Program; Terms Not Disclosed
NIKI
BenzingaAug 20, 2026, 12:06 PMBenzinga Insights
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Circle8 Group (NASDAQ:CIRC) shares increased by 18.2% to $0.77 during Thursday's pre-market session. The company's market cap stands at $60.1 million. The company's, Q2 earnings came out yesterday.
BIVI CIRC EDSA HYPD IVF
BenzingaJul 23, 2026, 12:04 PMBenzinga Newsdesk
Niki BioSolutions shares are trading higher after the company announced its subsidiary, DiamiR Biosciences, entered into agreement to provide Progressive Medical Research with Apolipoprotein E genotyping services.
NIKI